Journal article
Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery
Abstract
OBJECTIVE: To further examine anticoagulation reversal and clinical outcomes in dabigatran treated patients requiring urgent surgery or procedural interventions.
BACKGROUND: Idarucizumab, a humanized monoclonal antibody fragment, reverses dabigatran anticoagulation.
Authors
Levy JH; van Ryn J; Sellke FW; Reilly PA; Elsaesser A; Glund S; Kreuzer J; Weitz JI; Pollack CV
Journal
Annals of Surgery, Vol. 274, No. 3, pp. e204–e211
Publisher
Wolters Kluwer
Publication Date
September 2021
DOI
10.1097/sla.0000000000003638
ISSN
0003-4932